We speculate that the upregulated NCF2 in BLCa activates the NF-κB/VEGFA pathway through NADPH oxidase/ROS signaling, and ultimately promote BLCa angiogenesis and metastasis but more data are needed to confirm our hypothesis. This evidence concerns the gene FMO5 and bladder transitional cell carcinoma.